These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15972686)

  • 1. Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Lee S; Suvas S; Rouse BT
    J Immunol; 2005 Jul; 175(1):509-16. PubMed ID: 15972686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects.
    Kim B; Suvas S; Sarangi PP; Lee S; Reisfeld RA; Rouse BT
    J Immunol; 2006 Sep; 177(6):4122-31. PubMed ID: 16951377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology.
    Sharma S; Mulik S; Kumar N; Suryawanshi A; Rouse BT
    J Virol; 2011 Jun; 85(12):5995-6007. PubMed ID: 21471229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization.
    Banerjee K; Biswas PS; Kim B; Lee S; Rouse BT
    J Immunol; 2004 Jan; 172(2):1237-45. PubMed ID: 14707102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis.
    Lee S; Zheng M; Deshpande S; Eo SK; Hamilton TA; Rouse BT
    J Leukoc Biol; 2002 Mar; 71(3):469-76. PubMed ID: 11867684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis.
    Biswas PS; Banerjee K; Kim B; Rouse BT
    J Immunol; 2004 Mar; 172(6):3736-44. PubMed ID: 15004178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus.
    Mulik S; Xu J; Reddy PB; Rajasagi NK; Gimenez F; Sharma S; Lu PY; Rouse BT
    Am J Pathol; 2012 Aug; 181(2):525-34. PubMed ID: 22659469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis.
    Gimenez F; Mulik S; Veiga-Parga T; Bhela S; Rouse BT
    PLoS One; 2015; 10(12):e0141925. PubMed ID: 26720197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frontline Science: Aspirin-triggered resolvin D1 controls herpes simplex virus-induced corneal immunopathology.
    Rajasagi NK; Bhela S; Varanasi SK; Rouse BT
    J Leukoc Biol; 2017 Nov; 102(5):1159-1171. PubMed ID: 28584076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis.
    Zheng M; Deshpande S; Lee S; Ferrara N; Rouse BT
    J Virol; 2001 Oct; 75(20):9828-35. PubMed ID: 11559816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation.
    Kim B; Sarangi PP; Lee Y; Deshpande Kaistha S; Lee S; Rouse BT
    J Leukoc Biol; 2006 Dec; 80(6):1405-15. PubMed ID: 16997857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection.
    Suryawanshi A; Veiga-Parga T; Reddy PB; Rajasagi NK; Rouse BT
    J Immunol; 2012 Apr; 188(7):3434-46. PubMed ID: 22379030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.
    Bauer D; Lu M; Wasmuth S; Li H; Yang Y; Roggendorf M; Steuhl KP; Heiligenhaus A
    Graefes Arch Clin Exp Ophthalmol; 2006 Feb; 244(2):216-25. PubMed ID: 16047184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus.
    Lee S; Zheng M; Kim B; Rouse BT
    J Clin Invest; 2002 Oct; 110(8):1105-11. PubMed ID: 12393846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1.
    Rajasagi NK; Reddy PB; Suryawanshi A; Mulik S; Gjorstrup P; Rouse BT
    J Immunol; 2011 Feb; 186(3):1735-46. PubMed ID: 21187448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein.
    Biswas PS; Banerjee K; Zheng M; Rouse BT
    J Leukoc Biol; 2004 Oct; 76(4):868-75. PubMed ID: 15258192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-17 enhanced immunoinflammatory lesions in a mouse model of recurrent herpetic keratitis.
    Xia L; Zhang S; Cao Z; Hu Y; Yang H; Wang D
    Microbes Infect; 2013 Feb; 15(2):126-39. PubMed ID: 23159245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of bevacizumab (Avastin) in herpetic stromal keratitis (HSK).
    Hosseini H; Khalili MR
    Med Hypotheses; 2007; 69(3):568-70. PubMed ID: 17368959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
    Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of stromal keratitis by inhibition of neovascularization.
    Zheng M; Schwarz MA; Lee S; Kumaraguru U; Rouse BT
    Am J Pathol; 2001 Sep; 159(3):1021-9. PubMed ID: 11549594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.